FA
RMD icon

FDx Advisors’s ResMed RMD Stock Holding History

FDx Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-789
Closed -$204K – 196
2025
Q2 		$204K Buy
+789
New +$188K 0.06% 176
2023
Q3 		– Sell
-1,986
Closed -$434K – 751
2023
Q2 		$434K Sell
1,986
-2,471
-55% -$551K 0.02% 488
2023
Q1 		$928K Hold
4,457
– – 0.04% 315
2022
Q4 		$928K Buy
4,457
+105
+2% +$23.1K 0.04% 315
2022
Q3 		$950K Sell
4,352
-1,393
-24% -$317K 0.04% 290
2022
Q2 		$1.2M Sell
5,745
-85
-1% -$18.1K 0.05% 288
2022
Q1 		$1.41M Buy
5,830
+198
+4% +$47.9K 0.05% 262
2021
Q4 		$1.47M Sell
5,632
-284
-5% -$73.7K 0.04% 276
2021
Q3 		$1.56M Buy
5,916
+153
+3% +$41.8K 0.05% 255
2021
Q2 		$1.42M Buy
5,763
+482
+9% +$101K 0.05% 262
2021
Q1 		$1.02M Buy
5,281
+232
+5% +$46.5K 0.04% 288
2020
Q4 		$1.07M Buy
5,049
+236
+5% +$47.1K 0.04% 255
2020
Q3 		$825K Buy
4,813
+105
+2% +$19.4K 0.04% 268
2020
Q2 		$904K Sell
4,708
-1,476
-24% -$241K 0.05% 244
2020
Q1 		$911K Sell
6,184
-629
-9% -$100K 0.06% 206
2019
Q4 		$1.06M Buy
6,813
+179
+3% +$25.8K 0.06% 217
2019
Q3 		$896K Buy
6,634
+717
+12% +$93.9K 0.06% 234
2019
Q2 		$722K Buy
5,917
+278
+5% +$30.8K 0.03% 399
2019
Q1 		$586K Buy
5,639
+1,426
+34% +$147K 0.02% 432
2018
Q4 		$480K Buy
+4,213
New +$451K 0.04% 314

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

FDx Advisors's RMD Position: Q3 2025 in Review

FDx Advisors sold out of ResMed (RMD) in Q3 2025, closing a stake of 789 shares — an estimated $204K sold.

FDx Advisors first reported a position in RMD in Q4 2018 and held it in 20 quarters. The position peaked at $1.56M in Q3 2021. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • FDx Advisors reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • FDx Advisors sold 789 ResMed shares in Q3 2025, an estimated $204K.
  • FDx Advisors first reported a position in ResMed in Q4 2018 and held it in 20 quarters.
  • FDx Advisors's ResMed position peaked at $1.56M in Q3 2021.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on FDx Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.